" class="no-js "lang="en-US"> Foundation Medicine - Medtech Alert
Wednesday, July 30, 2025
Foundation Medicine | Pharmtech Focus

Foundation Medicine

About Foundation Medicine

Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.

For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.

Related Story

Foundation Medicine and Bristol Myers Squibb Expand Partnership to Focus on Companion Diagnostic Development

April 11 2023

Foundation Medicine, a pioneer in molecular profiling for cancer announced today, an expanded collaboration with […]

Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer

March 3 2023

Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, and Foundation […]

Roche Launches Comprehensive Genomic Profiling Kit to Expand Access to Personalised Cancer Research

October 25 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has launched the AVENIO Tumor Tissue […]